RBP16: a CRISPR-derived RNA-binding protein dependency signature predicts prognosis and therapeutic response in acute myeloid leukemia
Acta Biochimica et Biophysica Sinica · 01.11.2026
DOI: 10.3724/abbs.2026200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 02.11.2026. Verfasst von Yebing Liang und 15 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liang, Y., Zhang, Y., Shen, J., He, M., Liu, X., Cao, G., Lu, Y., Zhu, J., Zhou, Z., Tan, Y., Li, Z., Wu, S., Zhang, Y., Jin, P., Li, J., & Xiang, R. (2026). RBP16: a CRISPR-derived RNA-binding protein dependency signature predicts prognosis and therapeutic response in acute myeloid leukemia. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2026200
Vancouver
Liang Y, Zhang Y, Shen J, He M, Liu X, Cao G, et al. RBP16: a CRISPR-derived RNA-binding protein dependency signature predicts prognosis and therapeutic response in acute myeloid leukemia. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2026200
BibTeX
@article{Liang2026,
author = {Liang, Yebing and Zhang, Yuan and Shen, Jie and He, Mengke and Liu, Xiaxin and Cao, Guoquan and Lu, Yang and Zhu, Jinyang and Zhou, Zhiyue and Tan, Yayue and Li, Zeyi and Wu, Shishuang and Zhang, Yuquan and Jin, Peng and Li, Junmin and Xiang, Rufang},
title = {RBP16: a CRISPR-derived RNA-binding protein dependency signature predicts prognosis and therapeutic response in acute myeloid leukemia},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2026},
doi = {10.3724/abbs.2026200}
}
EUVIMED